The aims of this study are: 1. To assess the prevalence of prematurity, especially early prematurity, among T1D patients, and compare it to the prematurity prevalence among the non-diabetic general population in Israel. 2. To characterize epidemiological and clinical factors that differ between premature-born patients that developed T1D and those that have not, including the nutritional and therapeutic properties in NICU.
A national cohort study, including linkage of data from 13 pediatric diabetes centers and Israeli National Registries, including all patients with T1D born during 1990-2013. Data collected includes: ethnicity, gestational age, birth season, age and season at T1DM diagnosis, and presence of autoimmunity in family. The prevalence of prematurity among T1D is compared to the non-diabetic general population registry of 2000-2013. Additional comparisons are between T1D patients born term and preterm, aimed to unveil specific influencing clinical and epidemiological factors. In the latter part of the study, a multi-centered, paired case-control study is performed. Preterm born T1D patients will be paired to matched non-diabetic children at a ratio of 3:1, according to medical center, sex, gestational week of birth, season and year of birth. Data collected includes: ethnicity, family history of autoimmune diseases, age and type of first enteral nutrition, and pharmacological exposures.
Study Type
OBSERVATIONAL
Enrollment
3,600
data from charts and from registries will be compared
Assaf Harofeh Medical Center
Ẕerifin, Israel
prematurity prevalence among T1D patients
the number of premature born among those with type 1 diaetes compared to prematurity in health non diabetic population
Time frame: 1 years
food exposure of premature who developed T1DM compared with prematures who did not develop diabetes
75 files of premies with T1DM will be ccompared to 225 charts of premies, non diabetic for age of food initiation
Time frame: 1 years
Medications exposure in premature who developed T1DM compared with prematures who did not develop diabetes
75 files of premies with T1DM will be ccompared to 225 charts of premies, non diabetic for age and type of drugs initiation
Time frame: 1 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.